CHECK YOUR for your CE certification of completion.
|
|
- Shannon Miles
- 6 years ago
- Views:
Transcription
1 2017 course #1 self-study course contact us: phone toll free fax web dentistry.osu.edu/sms The Ohio State University College of Dentistry 305 W. 12th Avenue Columbus, OH ABOUT this COURSE READ the MATERIALS. Read and review the course materials. COMPLETE the TEST. Answer the eight question test. A total of 6/8 questions must be answered correctly for credit. SUBMIT the ANSWER FORM ONLINE. You MUST submit your answers ONLINE at: CHECK YOUR for your CE certification of completion. ABOUT your FREE CE TWO CREDIT HOURS are issued for successful completion of this self-study course for the OSDB biennium totals. CERTIFICATE of COMPLETION is used to document your CE credit and is ed to each course participant ALLOW 2 WEEKS for processing of your certificate. The Ohio State University College of Dentistry is an American Dental Association (ADA) Continuing Education Recognized Provider (CERP). The Ohio State University College of Dentistry is a recognized provider for ADA CERP credit. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at The Ohio State University College of Dentistry is approved by the Ohio State Dental Board as a permanent sponsor of continuing dental education. This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between The Ohio State University College of Dentistry Office of Continuing Dental Education and the Sterilization Monitoring Service (SMS). FREQUENTLY asked QUESTIONS Q: Who can earn FREE CE credits? A: EVERYONE - All dental professionals in your office may earn free CE credits. Each person must read the course materials and submit an online answer form independently. Q: Where can I find my SMS number? A: Your SMS number can be found in the upper right hand corner of your monthly reports, or, imprinted on the back of your test envelopes. The SMS number is the account number for your office only, and is the same for everyone in the office. Q: How often are these courses available? A: FOUR TIMES PER YEAR (8 CE credits).
2 2017 course #1 written by Vimi Mutalik, BDS, MDS edited by Sydney Fisher, BS Nick Kotlar, BS release date February 27, 2017 (8:30am EST) HPV-related Oropharyngeal Carcinoma Learning Objectives: 1. Learn key points about HPV-related OPSCC 2. Describe OPSCC prevalence and routes of acquisition 3. List and describe subtypes of HPV-related OPSCC 4. Identify the warning signs and methods of diagnosis, as well as disease treatment 5. Test knowledge by reviewing the True/False questions This is an OSDB Category B Supervised selfinstruction course INTRODUCTION The purpose of this CE self-study is to review the acquisition, prevalence, diagnosis and treatment of HPV-related oropharyngeal carcinomas, as well as disease subtypes and warning signs/symptoms. This CE self-study will also address prevention methods and the relationship between HPV and OSCC. last day to take the course at no charge March 31, :00pm EST Page 1
3 What is HPV-related OPSCC? The head and neck squamous cell carcinomas (HNSCC) are a heterogeneous group of neoplasm originating from various anatomic regions namely the oral cavity, oropharynx, hypopharynx, larynx and nasopharynx. Increased incidence of Human Papilloma Virus (HPV) as a cause of cancer in the head and neck region has made it important to analyze different subsites intraorally with caution. Although we refer to oral cancers in general, anatomically they are divided into oral cavity and the oropharynx. The cancers originating from the two anatomic sites, oral cavity and oropharyngeal region causes oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) respectively. Table 1: Features differentiating oral (OSCC) and oropharyngeal cancers (OPSCC) Parameters Oral cancer Oropharyngeal cancer Site Anterior oral mucosa Base of tongue, tonsils, posterior oral mucosa Etiology Smoking, alcohol Increased sexual partners, HPV Primary Clinical features White plaque, ulcer Enlarged lymph node in neck, dysphagia Incidence Decreasing Increasing Nodal involvement Present Present and may be the only sign of the disease Sex Males common (3:1) Males (5:1) predilection Social history Smoking (80-90%) Smoking (50-65%) Synergistic Alcohol Alcohol not a significant factor effect Prognosis 40% survival rate 80% survival rate Page 2
4 The cancers originating from these two anatomic sites (OSCC and OPSCC) vary considerably in terms of their statistics, etiologies, clinical signs and symptoms and response to treatment. HPV is now thought to be a risk factor in causation OPSCC (referring to posterior regions of the mouth) and not OSCC (common in anterior regions of the mouth). The discussion in this course is focused mostly on HPV-positive OPSCC which includes cancers from the base of tongue, tonsillar and pharyngeal wall. The OPSCC that are HPV-positive have risk factors related to sexual behavior, whereas HPV-negative cancers are strongly associated with tobacco and alcohol use. What are the key facts about HPV infection? Human papilloma virus (HPV) is the most common cause of sexually transmitted disease in the United States. HPV infection is very well-known in the causation of cervical cancers. However, it has been linked to various other cancers as well. In United States, new cases of cervical cancer have declined over the past 30 years because of increased use of Pap test, cervical smears or Pap smears. These tests enable professionals to identify early alterations in mucosa and are more curable than the invasive cancers. Although the rate of cervical cancer has been decreasing in women, the cancer on the back and sides of the throat, tonsils and base of tongue have increased significantly in men over the past few years. HPV has been thought to infect 90% of the U.S. population. About 12,000 Americans between ages of 15 to 24 are infected with HPV daily and about 26 million Americans have oral HPV infection on a given day. This definitely does not mean that all these patients develop OPSCC. In a vast majority of patients, the infection is cleared away within two years with their immune response and may not cause any health issues. There are nearly 200 strains of HPV; however, most of them do not cause cancers. Hence they are categorized into high-risk and low-risk subtypes. The lowrisk strains are associated most commonly with the causation of benign, noncancerous, genital and nongenital warts and the high-risk strains cause precancerous lesions which subsequently progress to cancer. The high-risk strains like HPV 16 and 18 are most commonly associated with occurrence of oropharyngeal cancers. Among them, HPV 16 is greater than 90% of times associated with oropharyngeal cancer. Page 3
5 HPV facts continued The Human Papilloma Virus (HPV) is a double stranded DNA virus that infects the epithelial cells of the skin and mucosa. These viruses have special affinity towards epithelium and are called epidermo-tropic. The mucosal surfaces that are moist like the throat, tongue, tonsils, vagina, cervix, vulva, penis and anus are more susceptible for development of diseases from this virus. Hence these viruses have also a major role in development of cervical, anal and penile cancers. When the virus contacts the epithelial surface it causes changes (koilocytic or viral induced changes) in the infected cells. The unique nature of transitional mucosa and the invaginations in the mucosal surface in the tonsils enables virus capture and makes it a preferential site for HPV. Moreover, the genetic features of HPV 16 facilitate an ideal environment for survival of these oncogenic (cancer-causing) organisms. Although HPV-positive and HPVnegative subtypes OPSCC exists, HPV is detectable in majority of the patients with oropharyngeal cancers. Therefore, in the oropharyngeal region the HPV-positive cases of OPSCC definitely outnumber the HPV-negative OPSCCs. Table 2: HPV facts sheet HPV is highly associated with oropharyngeal squamous cell carcinoma (OPSCC), but not oral squamous cell carcinoma (OSCC) Oropharyngeal squamous cell carcinoma (OPSCC) can be HPV-positive or HPVnegative. But the prognosis for the HPV-positive cases is better. Not all patients who have high-risk HPV in saliva develop oropharyngeal carcinoma. If you get HPV infection, you may or may not develop a precancerous or cancerous lesion. HPV, a primary cause for oral cancer (OSCC), lacks enough scientific evidence. HPV vaccines are safe and effective. Page 4
6 What is unique about HPV infection and OPSCC? The HPV-induced OPSCC have many unique features that distinguishes them from the conventional OSCC. Some studies indicate that the timing between the first exposure to HPV and the development of oropharyngeal cancer approximately exceeds 19 years. Oropharyngeal cancers (HPVinduced) present with very subtle clinical signs/symptoms and at most times the patient is unaware of it. Even the clinicians may find it hard to discover because the symptoms can be very elusive and painless. This is the main reason why OPSCC are usually identified at a later stage. Hence, it is very important that a very thorough examination is undertaken if the patient reports persisting symptoms of a period greater than two weeks. This is because the clinical signs and symptoms vary considerably from the obvious and classical tobacco-induced OSCC. Because the OPSCC have predilection for posterior regions for the mouth, accessibility to this area can be difficult and the primary lesion can be missed easily. Therefore, the tumor size in OPSCC is usually greater and the incidence of cervical and distant metastasis is also higher compared to OSCC. On the other hand, in a vast majority of patients, the infection is cleared away within two years with their immune response and does not cause any health issues. Some studies report that the infection with high-risk HPV usually last for months and is eventually cleared by the immune system. Persistent high-risk cases are the ones that eventually lead to development of malignancies or cancers. On the other hand, if you get HPV infection, you may or may not develop oral pre-cancer that eventually leads to oral cancer. Also, if you have a high-risk HPV infection, it is a myth to consider that you will definitely get HPV-induced OPSCC. The molecular alterations of HPV-positive head and neck cancer is in sharp contrast with HPV-negative head and neck cancers. p53 mutations, downregulated p16 activity and increased expression of prb is noted in HPV-negative head and neck cancers. These differences in the molecular profile indicate a lot about tumor behavior and its response to treatment. Page 5
7 How common is OPSCC? Head and neck cancers rank as the sixth most common cancer type worldwide. It accounts for nearly 5% of the cancers around the globe. Out of the 650,000 cases diagnosed worldwide each year, the annual mortality is about 300,000. Each year, approximately 263,000 cases of oral cavity cancer and 135,000 cases of pharyngeal cancer are diagnosed worldwide. The national head and neck malignant tumor registries indicate oral cavity to be the most predominant site, followed by larynx, hypopharynx, oropharynx, nose and paranasal sinuses and nasopharynx. It is important to note that the OSCC are associated with smoking and alcohol consumption, but the frequency of these cancers has declined in the US over the past 20 years. Figure 1: Incidence trends for Oral (OSCC) and Oropharyngeal (OPSCC) cancers Source: Chaturvedi AK et al., JCO, 2013 Page 6
8 However, the OPSCC has been on the rise with an increase by 28% during 1998 to In US, there is 225% increase in HPV-positive OPSCC from The annual rise in the number of cases is thought to be 70% and this would surpass the annual numbers of cervical cancers. The incidence of OPSCC is increasing in the economically developed countries like US, UK, Europe and Brazil. By 2020, the overall OPSCC burden in US is predicted to surpass cervical SCC. These changes have prompted recent epidemiological work to study differences between HNSCC related to tumor subsites and research on OPSCC is now taking a central position. How is the disease acquired? HPV usually involves the skin or the mucosal epithelium and causes abnormal changes. In most cases, the body fights off the infection and the cells that are infected get back to normal. When the body is unable to fight back because of other coexisting factors (like systemic illness or comorbidities, immunodeficiency status or habits like smoking), this virus can cause a range of diseases like genital warts, oral squamous papilloma, condyloma accuminatum and OPSCC. HPV is a sexually transmitted disease, which is now thought to be epidemic. Increased number of sex partners, open mouth kissing, practicing oral sex (from mouth to genital) and having sex with a partner who has had multiple sex partners are considered high risk factors. The incidence is greater in males as compared to females. This has been attributed to several reasons like a higher spread of infection through oral sex interaction on a woman. This is also further proved by the fact that an increased incidence of these cancers is seen more often in heterosexual men than homosexual men. Another possibility could be that, men mount a less robust immune response and are unable to protect themselves from the infection. A recent case control study also indicated that a high (>26) number of lifetime vaginalsex partners and 6 or more lifetime oral-sex partners are associated with an increased risk of development of OPSCC. The risk is also high in female partners with HPV-associated anogenital cancers and their male partners. On the contrary, it is interesting to note that the incidence of HPV infection in longterm sexual partners is not increased beyond the level compared to the general population. Page 7
9 Figure 2: Indicating the level of exposure to risk factors. Source: A vast majority of these patients have been current /past smokers, so smoking is thought to have a synergistic effect in the causation of these cancers. Immunodeficiency (HIV) infection is also thought to increase the risk for oral HPV infection. The immunodeficiency status is thought to increase the persistence of the infection thereby leading to development of oral HPVrelated disease. Focusing on the various modes of transmission, the risk of transmission from mother to child through saliva is questionable. The recent increased incidence of this disease mirrors the societal changes in sexual behavior that occurred in the developed world. The incidence of oropharyngeal SCC (OPSCC) in the developed countries is increasing as compared to Oral SCC (OSCC) in the developing countries. It is reported that changes in the sexual behavior in the developed world have led to an increase in the number of these OPSCC cases. Page 8
10 What are the different subtypes? Once acquired, the HPV infection goes through different stages/status in the body which is discussed below: Transient carrier status: Infections clears with no lesions, positive for serum antibody tests. It is the most common phase where the virus is present in mucosa and is identified by advanced molecular tests like in situ hybridization (ISH) or polymerase chain reaction (PCR). In majority of the cases, the virus is cleared within 1-2 years. Chronic carrier status: More frequently seen with high-risk subtypes and long term immunosuppression. This is an uncommon phase. There can be persistence of the high risk virus and this has strongly been implicated in the development of OPSCC. Chronic infection by HPV high-risk types confers to a 6- to 50-time increased risk of developing HPV-positive oropharyngeal cancer. Benign lesions: Papilloma, verruca (warts), condyloma accuminatum. Premalignant lesions: Cases of koilocytic dysplasia or HPV induced dysplasia have been described. However, the best described cases are in cervical dysplasia. Oropharyngeal cancer: Usually caused by HPV 16. About 90% of the patients who have this high-risk type definitely have OPSCC in the appropriate clinical setting. Page 9
11 What are the warning signs /symptoms of this disease? Figure 3: Oropharyngeal squamous cell carcinoma (OPSCC) presenting as an ulcero-proliferative growth in the posterior tonsillar area. Courtesy: Dr. Carl Allen, Department of Oral Pathology, The Ohio State University. Columbus Ohio OPSCC are commonly seen in Caucasian males, years of age, less exposed to tobacco and alcohol and with a relatively high socio-economic status. Patients with these cancers usually present with nonspecific symptoms of throat pain which is commonly seen during swallowing and abnormal sensation in the throat. With advanced disease, there is a neck swelling (lymph node enlargement) and dysphagia. The primary lesion is usually located in the tonsillar fossa or in the base of the tongue. Some patients also present with concern of ulcer on the throat, painless tonsil, alterations in voice and ear ache. In most cases, the neck swelling will be the primary concern since the nodal metastasis is aggressive. If the primary lesion is small or in the absence of throat symptoms, a diagnosis of node metastasis from carcinoma of unknown primary (CUP) is made. Page 10
12 How do we diagnose this condition? Although there are various chairside diagnostic tests to detect oral cancer, HPV-induced OPSCC are best identified by a thorough recording or medical/dental/social history from the patients, accompanied by visual and tactile head/ neck examination. Comprehensive oral examination is a key in establishing the diagnosis. Despite limited data showing improved survival, early detection of oral cancer/ pre-cancer is considered an integral part of a comprehensive hard/soft tissue examination that follows patient history and risk assessment. An ulcer or sore throat that has not healed for 2-3 weeks, difficult or painful swallowing, swollen but painless tonsil, recent change of voice/hoarseness, lump on the neck and an ear ache are the guiding features towards a possible early detection of these cancers. Like any diagnostic kit, this process of visual and tactile examination may not be 100% effective, so it is important to pursue if the symptoms have not resolved in 2-3 weeks time in order to arrive at a final diagnosis. Figure 4: Site predilection for OPSCC Source: Page 11
13 Diagnosis continued OraRisk sm HPV by OralDNA Labs and Quest Labs (2010) are commercially available kits usually indicated if there are traditional risk factors like sexual activity, family history of oral cancer, signs and symptoms of oral cancer and presence of a suspicious oral lesion. It is usually noninvasive and easy to use. The method is to gargle/swish with sterile saline for 30 seconds; expectorate into funneltop tube, ship, report. If the test is positive with no lesion, it is indicated to repeat the test again in six months and if it s positive, refer to oral surgery or the ENT department. On obtaining a biopsy from the primary site or a positive lymph node, these tumors represent an early T and a higher N stage, exhibiting moderate to poor cellular differentiation with basaloid/non-keratinizing morphology of tumor cells. The gold standard for assessing the HPV infections is the molecular techniques: in situ hybridization (ISH) or polymerase chain reaction (PCR). Both these techniques help to detect HPV deoxyribonucleic acid (DNA). cdna probe identifies the HPV DNA sequence, but includes episomal DNA (transitory infections). Several biomarkers have been useful; p16 is thought to be the most useful and reliable surrogate biomarker for this. It is noteworthy to mention that that evidence of both HPV DNA and evidence of viral DNA integration (p16+) are needed to diagnose an OPSCC as HPV-positive. What is the treatment and prognosis for HPV related cancers? The protocol for treatment of OPSCC is mainly determined by the stage of the disease. Single treatment modality, either surgery or radiotherapy is usually recommended for early disease. The HPV-positive tumors have better response to therapy. This is attributed to the presence of fewer genetic alterations, improved immune response contributing to higher radio sensitivity and the absence of filed cancerization effects. Moreover, the young age in association with less comorbidity may also contribute to better treatment outcomes. Comorbidities in the form of immunodeficiency states (HIV infection) or long term history of smoking may alter the prognosis and appropriate response to therapy. Tobacco smoking has been associated with worse prognosis in HPV-associated oropharyngeal cancers. The risk of progression of the disease and an increase death rate was directly proportional to the increased smoking history. Overall, HPV-positive cancers are associated with improved 3-year survival, 80% versus 40% for HPV-negative cancers. These cancers have a 28% reduction in risk of death and a 49% decrease in disease recurrence compared to the OSCC which are treated aggressively and have dismal clinical outcome. Page 12
14 How can we prevent HPV related Oropharyngeal cancers? Currently, two prophylactic vaccines, Gardasil (Merck, USA) and Cervarix (GlaxoSmithKline, UK) are available and recommended for adolescent massimmunization. Recently, Gardasil-9, which is a nanovalent vaccine and protects against nine strains of viruses, has been introduced. Since 2006, the federal drug administration (FDA) has approved these vaccines for HPV, all of which render protection against HPV 16 and 18. They are recommended for preteen girls and boys at age 11 to 12 years. The CDC has also recommended this for candidates who did not receive the vaccines when they were younger; including teen boys and girls, women through age 26 and young men through age 21. Both the vaccines are administered in a volume of 0.3mL intramuscularly. After the initial dose, two more booster doses are given, one within 1 or 2 months and another within 6 months. Although these vaccines have been very well-timed in terms of prevention, some patients receiving these vaccines experience pain, fatigue, redness, swelling, fever, GI symptoms, headache, dizziness, myalgia and arthralgia. One of the most common adverse reactions noted is local erythema at the site of injection. Rare cases of severe headache with hypertension, bronchospasm and gastroenteritis have also been documented. Gardasil has also been known to have caused infection, gastrointestinal disorders, nervous system disorders, reproductive and breast disorders. Although these vaccines have been effective, there is limitation in terms of their cost and expenses, as well as preparation and preservation. These vaccines have been designed specifically to reduce cervical cancer, but their effectiveness in minimizing oropharyngeal cancer (OPSCC) is still debatable. Broader subtype coverage of Gardasil-9 is expected to provide similar protection. Studies have also indicated that a decade after the first vaccine have been introduced, only 1 in 5 boys and 2 in 5 girls have been vaccinated. This number is considered low when compared to the health policy target of 80 percent. In addition to the vaccines, use of condoms, limiting the number of sex partners is also thought to decrease the incidence of causing these cancers. To date, Cervarix and Gardasil are considered very safe vaccines and have not been found to have a causal relationship with any serious health concern in a majority of the patients. Page 13
15 Can HPV cause OSCC in oral cavity? Figure 5: Oral squamous cell carcinoma (OSCC) presenting as an ulcer in the anterolateral and ventral portion of the tongue. Courtesy: Dr. Carl Allen, Department of Oral Pathology, The Ohio State University. Columbus Ohio. Comprehensive studies examining the site-specific prevalence of HPV have indicated that it is present in lip mucosa, floor of mouth, palate, tongue etc., in decreasing order of frequency. Since HPV DNA is present in reasonable subgroup of OSCC, it is important to note that not all HPV-positive tumors can be considered to be etiologically HPV driven. Molecular studies analyzing the HPV DNA status could detect viral oncogenes in only about 6-7% of the cases. This supports the notion that HPV is not biologically active in a majority of these oral cancers and is simply a bystander of this disease process. This separation is due to a different etiological process. This was also proven by the fact that most of these tumors were p16-negative, which indicates that the HPV was not transcriptionally active. The overall estimation is that less than 5% of OSCC are HPV-related. Hence, there is no consistent evidence of HPV as a risk factor for OSCC. Cases of HPV-positive pre-cancer in oral epithelial dysplasia, which is also called koilocytic dysplasia, has not been reported often. Studies also show that they have been both high-risk HPV-positive and p16-positive. A series of 20 cases of koilocytic dysplasia showed that the disease was common in men, and presented as white or papillary lesions and usually on ventral tongue. Among them, one recurred and one of them recurred (three times) in spite of excision with clear surgical margins. Up to 67% of those patients were followed for about 48 months and they had no evidence of disease. Hence the behavior off these lesions is considered identical to the HPV-negative lesion. Page 14
16 Abbreviations used: Head and neck squamous cell carcinoma (HNSCC) Oral squamous cell carcinoma (OSCC) Oropharyngeal squamous cell carcinoma (OPSCC) Human Papilloma Virus (HPV) Polymerase chain reaction (PCR) In-situ hybridization (ISH) Educational Links: Oral Cancer Foundation CDC UpToDate About the Author Vimi Mutalik, BDS, MDS Vimi Mutalik completed undergraduate studies at Rajiv Gandhi University in India, and continued on to receive a Masters in Oral Pathology from the same university. Currently a second year resident in oral pathology at The Ohio State University, Mutalik is studying HPV and its relation to oral pre-cancer. Future career plans are to provide patient care through biopsy service and clinical pathology. Mutalik can be reached at Mutalik.1@buckey .osu.edu Neither I nor my immediate family have any financial interests that would create a conflict of interest or restrict my judgement with regard to the content of this course Page 15
17 References Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, Popat S, Sullivan M. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, Oral Oncol Nov; 47(11): Liu H, Liu XW, Dong G, Zhou J, Liu Y, Gao Y, Liu XY, Gu L, Sun Z, Deng D. P16 Methylation as an Early Predictor for Cancer Development from Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study. EBioMedicine Mar 23; 2(5): Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, Oral Surg Oral Med Oral Pathol Oral Radiol Endod Jun; 91(6): Nankivell P, Williams H, Webster K, Pearson D, High A, MacLennan K, Senguven B, McConkey C, Rabbitts P, Mehanna H. Investigation of p16(ink4a) as a prognostic biomarker in oral epithelial dysplasia. J Oral Pathol Med Apr; 43(4):245-9 Rettig EM, D Souza G. Surg Oncol Clin N Am (2015) Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campi. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis ( ). Ann Oncol Oct; 19(10): Uddin MN, Kouzi SA and Hussain MD. Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System. J Pharm Sci. 2015; 18(2) More references available on request Page 16
18 Post-Test Instructions Answer each question ONLINE (link provided on SMS website) Answer post-course survey questions and click Finish Deadline is March 31, 2017 (4:00pm EST) 1 T F In developed countries, the incidence of oral squamous cell carcinoma (OSCC) is more than oropharyngeal carcinoma (OPSCC). 2 T F Oropharyngeal squamous cell carcinoma (OPSCC) is commonly seen in males. 3 T F The Human papilloma virus is usually cleared within 1-2 years in a patient with a good immune status. 4 T F The prognosis for HPV-positive cancer is worse than HPV-negative cancer. 5 T F Ulceration and pain on the anterior tongue is the most common presenting sign/symptom in patients with oropharyngeal squamous cell carcinoma (OPSCC). 6 7 T T F F HPV 16 and 18 are the strains associated in development of oropharyngeal squamous cell carcinoma (OPSCC). A patient presenting with swollen lymph nodes on his neck in the absence of any signs of disease in the oral and oropharyngeal region, node metastasis from Carcinoma of Unknown Primary (CUP) may be considered in the differential diagnosis. Director John R. Kalmar, DMD, PhD Kalmar.7@osu.edu Program Manager Sydney Fisher, BS Fisher.1057@osu.edu Program Assistant Nick Kotlar, BS Kotlar.2@osu.edu 8 T F HPV vaccines are 100% effective in preventing oropharyngeal cancers (OPSCC).
Objectives. HPV Classification. The Connection Between Human Papillomavirus and Oropharyngeal Cancer 6/19/2012
The Connection Between Human Papillomavirus and Oropharyngeal Cancer Jennifer L. Cleveland, DDS, MPH Dental Officer/Epidemiologist OSAP Annual Symposium June 23, 2012 Atlanta, GA National Center for Chronic
More informationUpdate of the role of Human Papillomavirus in Head and Neck Cancer
Update of the role of Human Papillomavirus in Head and Neck Cancer 2013 International & 12 th National Head and Neck Tumour Conference Shanghai, 11 13 Oct 2013 Prof. Paul KS Chan Department of Microbiology
More informationHPV and Head and Neck Cancer: What it means for you and your patients
HPV and Head and Neck Cancer: What it means for you and your patients Financial Disclosure: None November 8, 2013 Steven J. Wang, MD Associate Professor Department of Otolaryngology-Head and Neck Surgery
More informationRECORD or PRINT THE CONFIRMATION ID This unique ID is displayed upon successful submission of your answer form.
2013 course four self-study course The Ohio State University College of Dentistry is a recognized provider for ADA CERP credit. ADA CERP is a service of the American Dental Association to assist dental
More informationHUMAN PAPILLOMAVIRUS
HUMAN PAPILLOMAVIRUS HUMAN PAPILLOMAVIRUS The Human Papillomavirus (HPV) is responsible for 60% of cancers of the throat including base of the tongue and tonsils. AN OVERVIEW TO HUMAN PAPILLOMAVIRUS Human
More informationHPV & RELATED DISEASES
GAY MEN, HPV & ANAL CANCER THEBOTTOMLINE.ORG.AU HPV & RELATED DISEASES WHAT IS HPV? The Human Papilloma Virus (HPV) is not one virus, but a family of about 200 different ones that cause common warts, genital
More informationWhat You Should Know. Exploring the Link between HPV and Cancer.
What You Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a virus
More informationHead and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.
Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S. Associate Professor Division of Head and Neck Surgery Department of Otolaryngology-Head and
More informationHPV is the most common sexually transmitted infection in the world.
Hi. I m Kristina Dahlstrom, an instructor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. My lecture today will be on the epidemiology of oropharyngeal
More informationHPV/Cervical Cancer Resource Guide for patients and providers
DHS: PUBLIC HEALTH DIVISION IMMUNIZATION PROGRAM HPV/Cervical Cancer Resource Guide for patients and providers Independent. Healthy. Safe. Oregon HPV Provider Resource Kit: Table of Contents Provider Information
More informationOral HPV infection and the changing epidemiology in head and neck cancer
Oral HPV infection and the changing epidemiology in head and neck cancer Daniel Beachler, PhD, MHS Johns Hopkins School of Public Health Department of Epidemiology Southwest Region s Dental PBRN Meeting
More informationHPV, Oral Sex and Oral Cancer: A (not so) New Epidemic. Alice M. Horowitz, PhD AACDP April 23,2017 Albuquerque, NM
HPV, Oral Sex and Oral Cancer: A (not so) New Epidemic Alice M. Horowitz, PhD AACDP April 23,2017 Albuquerque, NM CDC Estimates. Nearly 80 million Americans have HPV and 14 million new infections occur
More informationHPV-Associated Disease and Prevention
HPV-Associated Disease and Prevention Odessa Regional Medical Center May 28, 2015 Erich M. Sturgis, MD, MPH Professor Department of Head & Neck Surgery Department of Epidemiology Christopher & Susan Damico
More informationWhat Parents Should Know
What Parents Should Know Exploring the Link between HPV and Cancer www.indianacancer.org What is HPV? The Human papillomavirus (HPV) is the most common sexually transmitted infection (STI). An STI is a
More informationHuman Papillomavirus Lafayette Medical Education Foundation June 19, 2018
Human Papillomavirus Lafayette Medical Education Foundation June 19, 2018 Katherine McHugh, MD Indiana University Dept. of OB/GYN kwmchugh@iupui.edu Take Home Points: - Risk factors for HPV infection:
More informationHPV-Related Head and Neck Squamous Cancers
2015 Wisconsin Comprehensive Cancer Control Summit Aligning Partners, Priorities, and the Plan HPV-Related Head and Neck Squamous Cancers MCW Department of Otolaryngology and Communication Sciences MCW
More informationWritten By: Dr. Sara Solomon BSc Physical Therapy, DMD
HEALTH & WELLNESS HPV LINKED TO Written By: Dr. Sara Solomon BSc Physical Therapy, DMD The CDC believes that nearly 80% of Americans will be infected with HPV at some point in their lifetime 1. Dr. Sara
More informationHuman Papillomavirus
Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and
More informationFocus. International #52. HPV infection in High-risk HPV and cervical cancer. HPV: Clinical aspects. Natural history of HPV infection
HPV infection in 2014 Papillomaviruses (HPV) are non-cultivable viruses with circular DNA. They can establish productive infections in the skin (warts) and in mucous membranes (genitals, larynx, etc.).
More informationOral Cancer Risk and Detection
Oral Cancer Risk and Detection Evan M. Graboyes, MD Assistant Professor Department of Otolaryngology-Head & Neck Surgery Cancer Control Program, Hollings Cancer Center Medical University of South Carolina
More informationEXPOSING DANGERS OF HUMAN PAPILLOMAVIRUS IN BOTH MEN AND WOMEN
EXPOSING DANGERS OF HUMAN PAPILLOMAVIRUS IN BOTH MEN AND WOMEN Aishatu Abdullahi Adamu 3rd Year Student, Department of Medical Laboratory Technology, NIMS University Jaipur (India) ABSTRACT The human papillomavirus
More informationOral Cancer FAQs. What is oral cancer? How many people are diagnosed with oral cancer each year?
Oral Cancer FAQs What is oral cancer? Oral cancer or oral cavity cancer, is cancer that starts in the mouth. Areas affected by this type of cancer are the lips, the inside lining of the lips and cheeks
More informationEvaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S.
Evaluation and Management of Head and Neck Cancer in Patients with Fanconi anemia David I. Kutler, M.D., F.A.C.S. Residency Site Director Weill Cornell Medical Center Associate Professor Division of Head
More informationHPV FREE IDAHO. Fundamentals of HPV Bill Atkinson, MD MPH
HPV FREE IDAHO Fundamentals of HPV Bill Atkinson, MD MPH You are the Key to HPV Cancer Prevention William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition February
More informationPresented By Shirley Jordan Seay PhD, RN, CTR
Presented By Shirley Jordan Seay PhD, RN, CTR Objectives Discuss the unintended consequences of HPV infection. Identify cancers associated with HPV infection HPV Associated Cancers Cervix Vagina Vulva
More informationHuman Papillomavirus in Head and Neck Cancer
Human Papillomavirus in Head and Neck Cancer Adam L. Holtzman, M.D. ACLI Medical Section Meeting 2019 Disclosures Employment Relationship University of Florida Compensation, Remuneration, Funding None
More informationNotice of Faculty Disclosures
William C. Faquin, MD, PhD Professor of Pathology Harvard Medical School Director of Head and Neck Pathology Massachusetts Eye and Ear Massachusetts General Hospital FNA OF SQUAMOUS CYSTS OF THE HEAD AND
More informationOral Cavity and Oropharynx Cancer Trends
Oral Cavity and Oropharynx Cancer Trends Darien Weatherspoon, DDS, MPH Diplomate, American Board of Dental Public Health Program Officer, National Institute of Dental and Craniofacial Research National
More informationNEWS A Publication of Vantage Oncology, Tri-State Radiation Oncology Centers - TROC
Congressman Larry Buschon Visits Evansville Cancer Center Nationwide, physicians who provide care to Medicare patients are feeling the impact of significant reimbursement cuts for their services. Members
More informationSmoking, human papillomavirus infection, and p53 mutation as risk factors in oropharyngeal cancer: a case-control study
RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Smoking, human papillomavirus infection, and p53 as risk factors in oropharyngeal cancer: a case-control study PKS Chan *, JSY Chor, AC Vlantis, TL
More informationBOZEMAN HEALTH CANCER CENTER ANNUAL REPORT 2017
BOZEMAN HEALTH CANCER CENTER ANNUAL REPORT 2017 Gynecological Cancer Care and Treatment Advancements in Integrated Treatment Phronsie Sprenger, LCSW Cancer is an illness that affects every part of a person
More informationMANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS
MANAGEMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANER: HPV AND NON-HPV MEDIATED CANCERS Kyle Arneson, MD PhD Avera Medical Group Radiation Oncology Avera Cancer Institute 16 th Annual Oncology Symposium September
More informationHuman Papillomavirus Testing in Head and Neck Carcinomas
Human Papillomavirus Testing in Head and Neck Carcinomas Guideline from the College of American Pathologists Early Online Release Publication: Archives of Pathology & Laboratory Medicine 12/18/2017 Overview
More informationHPV & Throat Cancer. Information for patients, their families and loved ones
HPV & Throat Cancer Information for patients, their families and loved ones 8 Contents of this guide Introduction - HPV and throat cancer 2 What is HPV? 3 How common is HPV? 4 How do you catch HPV? 5 When
More informationOral Cancer and Common Oral Lesions seen in HIV Seropositive Patients. Gwen Cohen Brown DDS, FAAOMP Professor New York City College of Technology
Oral Cancer and Common Oral Lesions seen in HIV Seropositive Patients Gwen Cohen Brown DDS, FAAOMP Professor New York City College of Technology Program Objectives Recognize the oral health needs of the
More informationSexually Transmitted. Diseases
Sexually Transmitted Diseases How can I get an STD? Many STDs are carried and transmitted through semen and vaginal fluids. Some STDs can be spread through skin to skin contact Mother to child STDs: Signs
More informationHuman Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses
More informationBiology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s)
Biology 3201 Unit 2 Reproduction: Sexually Transmitted Infections (STD s/sti s) STI s once called venereal diseases More than 20 STIs have now been identified most prevalent among teenagers and young adults.
More informationAn update on the Human Papillomavirus Vaccines. I have no financial conflicts of interest. Case 1. Objectives 10/26/2016
An update on the Human Papillomavirus Vaccines Karen Smith-McCune Professor, UCSF Department of Obstetrics, Gynecology and Reproductive Sciences John Kerner Endowed Chair I have no financial conflicts
More informationThe Biology of HPV Infection and Cervical Cancer
The Biology of HPV Infection and Cervical Cancer Kaitlin Sundling, M.D., Ph.D. Clinical Instructor Faculty Director, Cytotechnology Program Wisconsin State Laboratory of Hygiene and University of Wisconsin
More informationWhat you need to know to: Keep Yourself SAFE!
What you need to know to: Keep Yourself SAFE! What are sexually transmitted diseases (STDs)? How are they spread? What are the different types of STDs? How do I protect myself? STDs are infections or diseases
More informationHPV AND CERVICAL CANCER
HPV AND CERVICAL CANCER DR SANDJONG TIECHOU ISAAC DELON Postgraduate Training in Reproductive Health Research Faculty of Medicine, University of Yaoundé 2007 INTRODUCTION CERVICAL CANCER IS THE SECOND
More informationUniversity Health Services at CMU STI Awareness Month specials for students:
University Health Services at CMU STI Awareness Month specials for students: -Free condoms during April (10 per student) -Free walk-in rapid HIV testing April 22-27 (no appointment needed) -STI Screening
More informationA Case Review: Treatment-Naïve Patient with Head and Neck Cancer
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationSCCPS Scientific Committee Position Paper on HPV Vaccination
SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical
More informationHPV infections and potential outcomes
CONTENTS Preface by Silvia de Sanjosé... 33 Preface by Jacob Bornstein... 37 Author s note... 39 Acknowledgments... 45 CHAPTER 1 HPV infections and potential outcomes HPV: What it is, where it is and what
More informationHPV. In Perspective SAMPLE. Do not reproduce (c) 2016 American. Sexual Health. Association
HPV In Perspective TABLE OF CONTENTS What is HPV? Symptoms or No Symptoms Genital Warts Abnormal Cell Changes How does someone get HPV? HPV Vaccines Is prevention possible? HPV, Pregnancy, and Children
More informationTowards the elimination of HPV
Towards the elimination of HPV Richard Hillman June 11th 2018 Potential conflicts of interest Potential Conflicts of Interest Declaration CSL research + travel + support for student MSD International Scientific
More informationHead and Neck SCC. HPV in Tumors of the Head and Neck. Overview. Role of HPV in Pathogenesis of Head & Neck Tumors
HPV in Tumors of the Head and Neck Christina Kong, M.D. Associate Professor, Stanford Dept of Pathology Director, Cytopathology Laboratory & Cytopathology Fellowship ckong@stanford.edu Head and Neck SCC
More informationGARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant
SWISS SUMMARY OF ACTIVITIES IN THE RISK MANAGEMENT PLAN FOR GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant Active Substance: Human Papillomavirus 9-valent Vaccine, Recombinant MAH / MAA
More informationHPV Transmission. Rachel Winer, PhD, MPH Department of Epidemiology University of Washington
HPV Transmission Rachel Winer, PhD, MPH Department of Epidemiology University of Washington rlw@u.washington.edu Disclosure Information I have no financial relationships to disclose. Human Papillomavirus
More informationFree human papillomavirus (HPV) and hepatitis A and hepatitis B vaccines
Free human papillomavirus (HPV) and hepatitis A and hepatitis B vaccines for children in Grade 4 of primary school Vaccination, the best protection Form to complete inside Vaccination This leaflet contains
More informationHuman Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita
Human Papillomavirus Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita What is Genital HPV Infection Human papillomavirus is
More informationHow to Prevent Sexually Transmitted Diseases
ACOG publications are protected by copyright and all rights are reserved. ACOG publications may not be reproduced in any form or by any means without written permission from the copyright owner. This includes
More informationHuman Papillomavirus (HPV) in Patients with HIV.
Human Papillomavirus (HPV) in Patients with HIV www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS residents with HIV who are screened for HPV-related dysplasia and managed effectively.
More informationTruth THE STORY OF HIV/ CONSEQUENCE. Women's Ministries Department General Conference of Seventh-day Adventists
Truth OR CONSEQUENCE THE STORY OF HIV/ AIDS Women's Ministries Department General Conference of Seventh-day Adventists What is? HIV (Human Immunodeficiency Virus) is a virus that causes AIDS (Acquired
More informationWhat is the Safety and Efficacy of Vaccinating the Male Gender to Prevent HPV Related Neoplastic Disorders in Both the Male and Female Genders
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 What is the Safety and Efficacy of Vaccinating
More informationQuick Study: Sexually Transmitted Infections
Quick Study: Sexually Transmitted Infections Gonorrhea What is it: A bacterial infection of the genitals, anus, or throat. How common: The CDC estimates 820,000 people in the United States get Gonorrhea
More informationConcern for recurrence Stable virus especially in freeze dried form High infectivity in humans Vaccine supplies are limited No specific antiviral
poxviruses Poxviruses Infect humans, birds, mammals, and insects. DsDNA brick shaped, enveloped multiply in the cytoplasm, 100x200x300 nm. lack normal capsid instead, layers of lipoprotiens and fibrils
More informationWhat are the implications of HPV in the biology of Head and Neck Cancer?
What are the implications of HPV in the biology of Head and Neck Cancer? Raquel Ajub Moyses Friday, August 2nd, 2013 Disclosure Raquel Ajub Moyses has no significant financial relationship with any commercial
More informationMake Love Not Warts Genital Warts
Patricia Wong, MD 735 Cowper Street Palo Alto, CA 94301 650-473-3173 www.patriciawongmd.com Make Love Not Warts Genital Warts Genital warts are the most common sexually transmitted disease. The lifetime
More informationAlberta Head and Neck Cancer Priority Setting Project
Alberta Head and Neck Cancer Priority Setting Project About You 1. Which group best describes you? (Check all that apply). * A person diagnosed with cancer of the head and neck A family member or caregiver
More informationHow is it transferred?
STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live
More informationHPV Vaccines. What is HPV? Can a vaccine help prevent HPV?
What is HPV? HPV Vaccines HPV is short for human papilloma virus. HPVs are a group of more than 150 related viruses. Each HPV virus in the group is given a number, which is called an HPV type. HPVs are
More informationLTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS
LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS LTASEX.INFO! IN AIDS is a treatable complication of advanced HIV infection.
More informationDiseases of oral cavity
Diseases of oral cavity Diseases of Teeth and Supporting Structures Inflammatory/Reactive Lesions Infections Oral Manifestations of Systemic Disease Precancerous and Cancerous Lesions Odontogenic Cysts
More informationApril Blackmon NURS7440/7550. Gardasil. Auburn University/Auburn Montgomery
April Blackmon Health Promotion Paper NURS7440/7550 Gardasil Auburn University/Auburn Montgomery 2 Introduction Human papillomavirus or HPV is a virus that will affect an estimated 75%- 80% of males and
More informationOriginal Research Article
ASSESSMENT OF HUMAN PAPILLOMA VIRUS SUBTYPES BY POLYMERASE CHAIN REACTION AND THEIR IMPACT ON THE DEGREE OF DYSPLASIA IN ORAL LEUKOPLAKIA Submitted on: XXXX Dr. N. Kannan, Dr Teja Srinivas, Dr. Rakesh
More informationBackground HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou
Case-Control Control Study of Human Papillomavirus avi and Oropharyngeal Cancer D Souza, DSouza, et al. NEJM, May 2007 Tony Sung Julia Beaver Journal Club September 9, 2009 Background HPV causes virtually
More informationOROPHARYNX CANCER. Anthony Zeitouni, MD, FRCSC. Co-Lead, Head Neck Cancer Rossy Cancer Network
OROPHARYNX CANCER Anthony Zeitouni, MD, FRCSC Co-Lead, Head Neck Cancer Rossy Cancer Network CFPC CoI Templates: Slide 1 FACULTY/PRESENTER DISCLOSURE Faculty: Dr Anthony Zeitouni Relationships with commercial
More informationImmunise against HPV
Immunise against HPV (Human Papillomavirus) Helps prevent cancers caused by HPV infection Information for young people and their families and whānau Human papillomavirus (HPV) immunisation helps protect
More informationSEXUALLY TRANSMITTED DISEASES (INFECTIONS)
SEXUALLY TRANSMITTED DISEASES (INFECTIONS) HIV/AIDS - TRANSMISSION Sexual intercourse Anal, oral, & vaginal Multiple partners Sharing needles Mother to infant Born or breast milk Blood transfusions Open
More informationHPV-Associated Cancers
HPV-Associated Cancers HPV Vaccination Summit: Debunking Myths and Preventing Cancer Thursday, February 2, 2017 St. Luke s Anderson Center Chris Johnson, MPH Cancer Data Registry of Idaho Outline Human
More informationRESULT OF SURVEY OF 1705 LAWSUITS* ORAL CANER: A significant Public Health Concern. ORAL CANCER: Other Epidemiologic Facts
FAILURE TO DIAGNOSE ORAL CANCER AND OTHER PATHOLOGIC CONDITIONS OF THE ORAL CAVITY Kalu U.E. Ogbureke, BDS, MSc, DMSc, JD, FDSRCS, FDSRCPS, FDSRCSEd, FRCPath Diplomate, American Board of Oral and Maxillofacial
More informationChapter 3. Neoplasms. Copyright 2015 Cengage Learning.
Chapter 3 Neoplasms Terminology Related to Neoplasms and Tumors Neoplasm New growth Tumor Swelling or neoplasm Leukemia Malignant disease of bone marrow Hematoma Bruise or contusion Classification of Neoplasms
More informationFirst of all, the pathophysiology
Welcome. My name is Eric Sturgis and I m a Professor in Head and Neck Surgery with a joint appointment in the Department of Epidemiology at The University of Texas MD Anderson Cancer Center. And today
More informationMYTHS OR FACTS OF STI s True or False
Viral STI s MYTHS OR FACTS OF STI s True or False 1. There is no cure for herpes or AIDS. 2. Condoms protect against STI s. 3. If two people are free from STI s and have no other sexual partners, they
More informationHPV facts about the virus, the vaccine and what this means for you. Answers to common questions asked by adolescents and young adults
HPV facts about the virus, the vaccine and what this means for you Answers to common questions asked by adolescents and young adults HPV and vaccination What is HPV and why should I be vaccinated against
More informationTake out CST test corrections What do you know about STDs?
Assignment #5 STDs LO: To understand sexually transmitted diseases. EQ: What are all of the ways to contract STDs? (4-5 sentences underlining key words) AGENDA 5/12-5/13 1. Group work 2. Notes Homework
More information3/2/2017. The School Nurse Role In Human Papillomavirus Vaccine Series Completion OBJECTIVES
The School Nurse Role In Human Papillomavirus Vaccine Series Completion Karen Schwind BSN RN NCSN TSNO Region 1 Conference March 4, 2017 OBJECTIVES The attendee will: Understand the disease prevention
More informationEpidemiological Characteristics of Oral and Oropharyngeal Squamous Cell Carcinoma H.S. van Monsjou
Epidemiological Characteristics of Oral and Oropharyngeal Squamous Cell Carcinoma H.S. van Monsjou Summary The epidemiology of head and neck cancer has shown remarkable changes in past decades (chapter
More information9/11/2018. HPV Yoga. Human Papillomavirus. Human Papillomavirus (HPV) Disease. Most common sexually transmitted infection in the U.S.
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Human Papillomavirus September 2018 Chapter 11 Photographs and images included in this presentation
More informationPerspectives on Oropharyngeal Cancer: Scientific Overview, Clinical Expertise, and Personal Experience. February 13, 2019
Perspectives on Oropharyngeal Cancer: Scientific Overview, Clinical Expertise, and Personal Experience February 13, 2019 Housekeeping Items All attendees are muted. If you are using your phone, please
More informationSTI s. (Sexually Transmitted Infections)
STI s (Sexually Transmitted Infections) Build Awareness In Canada and around the world, the trend is clear: sexually transmitted infections (STIs) are on the rise. One of the primary defenses in the fight
More informationClinically Microscopically Pathogenesis: autoimmune not lifetime
Vulvar Diseases: Can be divided to non-neoplastic and neoplastic diseases. The neoplastic diseases are much less common. Of those, squamous cell carcinoma is the most common. most common in postmenopausal
More informationUnder-appreciated Cancers Associated with HPV Texas Immunization Summit
Under-appreciated Cancers Associated with HPV 2014 Texas Immunization Summit Erich M. Sturgis, MD, MPH Professor Department of Head & Neck Surgery Department of Epidemiology No C.O.I., disclosures, or
More informationF.C. Shakhtatinskaya, L.S. Namazova-Baranova, V.K. Tatochenko, D.A. Novikova, T.E. Tkachenko
F.C. Shakhtatinskaya, L.S. Namazova-Baranova, V.K. Tatochenko, D.A. Novikova, T.E. Tkachenko Scientific Center of Children s Health, Moscow, Russian Federation Human Papilloma Virus. Prevention of HPV-Associated
More information1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal
Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa
More informationHPV doesn t concern men?
Think HPV doesn t concern men? What you should know about HPV-related cancers and genital warts. One infected partner may be all it takes to get HPV. HPV=human papillomavirus Trying to decide if GARDASIL
More informationCarcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY
Carcinoma of Unknown Primary site (CUP) in HEAD & NECK SURGERY SEARCHING FOR THE PRIMARY? P r o f J P P r e t o r i u s H e a d : C l i n i c a l U n i t C r i t i c a l C a r e U n i v e r s i t y O f
More informationDiseases of the vulva
Diseases of the vulva 1. Bartholin Cyst - Infection of the Bartholin gland produces an acute inflammation within the gland (adenitis) and may result in an abscess. Bartholin duct cysts - Are relatively
More informationCancer of the Head and Neck and. HPV Infection. Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic
Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic Disclaimer I have no relevant financial relationships with the manufacturer(s)
More informationCERVICAL CANCER FACTSHEET. What is cervical cancer?
CERVICAL CANCER FACTSHEET What is cervical cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at a grassroots level. Take-up
More informationHuman Papillomavirus (HPV): Vaccine-Preventable Disease
Human Papillomavirus (HPV): Vaccine-Preventable Disease Texas Department of State Health Services (DSHS) Immunization Program, Health Service Region 6/5S Sabrina Stanley, CHES, MPHc Crystal Thomas, MPH
More informationOVERVIEW SEXUALLY TRANSMITTED INFECTIONS REPORTS STI BASICS WATCH OUT! HOW TO PREVENT STIs. Sexually Transmitted Infections Reports
UNIT NINE: UNDERSTANDING & PREVENTING SEXUALLY TRANSMITTED INFECTIONS OVERVIEW SEXUALLY TRANSMITTED INFECTIONS REPORTS STI BASICS WATCH OUT! HOW TO PREVENT STIs Overview When compared to the other industrialized
More informationWOMENCARE. Herpes. Source: PDR.net Page 1 of 8. A Healthy Woman is a Powerful Woman (407)
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Herpes Basics: Herpes is a common viral disease characterized by painful blisters of the mouth or genitals. The herpes simplex virus (HSV) causes
More informationReal-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage
Real-life challenges in implementing public strategies for HPV vaccination in developing countries, and strategies to increase immunization coverage Prof. Charbell Miguel Haddad Kury, MD Pediatrician Infectious
More informationHPV HUMAN PAPILLOMA VIRUS
HPV HUMAN PAPILLOMA VIRUS WHAT IS HPV? HPV is the most common sexually transmitted infection (STI). There are more than 40 HPV types that can infect the genital areas of males and females. Four of these
More informationOral Cavity and Pharynx Cancer
Oral Cavity and Pharynx Cancer Figure 18 Definition: Oral cancer begins in the mouth and can include the lips, cheeks, teeth, gums, the floor of the tongue, the roof of the mouth, and the front two-thirds
More informationThe Human Papillomavirus Vaccine
The Human Papillomavirus Vaccine Publication No. 2011-114-E 9 November 2011 Sonya Norris Social Affairs Division Parliamentary Information and Research Service The Human Papillomavirus Vaccine (Background
More information